An announcement from Virax Biolabs Group Ltd. Class A ( ($VRAX) ) is now available. On December 3, 2025, Virax Biolabs Group Limited announced a ...

The influenza virus or flu is a contagious respiratory illness that can generate mild, moderate, or severe symptoms. Healthy ...

A new imaging approach combining AFM and fluorescence microscopy allowed researchers to observe influenza entry at high ...

HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...

In a paper published in Trends in Immunology, scientists and doctors highlight the importance of studying long COVID in the ...

"There are some signs that another big norovirus season is ahead of us," Emory University Professor Ben Lopman told Newsweek.

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today the ...

Pneumonia is a disease that burdens the health care system with more than 1.2 million emergency room visits each year and ...

Healthcare has outperformed tech and is among the top performing stock sector in the last three months. Here are one ETF ...

A lawsuit from the AG's office accused Travis Broughton and his two stem cell companies of engaging in "false, misleading, ...